Research on the Influence of Mukbang on Brain Activation in Children With Cancer Based on fMRI
Launched by WEI XIA, PHD · Jun 19, 2023
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how "Mukbang," which is a popular trend of watching people eat large amounts of food, can help improve appetite in children with cancer who are undergoing treatments like chemotherapy and radiotherapy. The study will use a special type of brain scan called fMRI to see how watching Mukbang might affect the brain and encourage these children to eat better during their treatment.
To participate in this trial, children aged 10 to 18 who have been diagnosed with any type of cancer (except brain tumors) and are currently receiving treatment can apply. They should also have a noticeable decrease in appetite. However, children with serious other health issues, certain mental or physical disabilities, or conditions that prevent them from comfortably watching videos will not be eligible. If they join the study, participants will watch Mukbang videos while their brain activity is monitored, helping researchers understand how these videos might support better eating habits during tough treatment times.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children with cancer aged between 10 to 18 years old;
- • diagnosed with any tumor or cancer other than brain tumor before the age of 18;
- • having received or are receiving inpatient treatment;
- • both the patient and the guardian can communicate in Chinese;
- • children with moderate or higher symptoms of decreased appetite were screened for the Therapy-Related Symptom Checklist for Children.
- Exclusion Criteria:
- • a diagnosis of a serious disease other than a tumor, especially a brain disease such as epilepsy and organic psychosis, was identified from the case;
- • unable to complete communication due to serious mental or physical illness, such as cognitive impairment or unclear consciousness;
- • children with eye or ear dysfunction that prevents them from watching and listening to videos;
- • with braces, cardiac pacemakers and other items with iron magnetism that cannot be removed from the body;
- • people who suffer from claustrophobia, ADHD, and other problems of staying quiet in confined spaces for long periods of time.
About Wei Xia, Phd
Wei Xia, PhD, is a distinguished clinical trial sponsor with extensive expertise in clinical research and development. With a strong background in biomedical sciences, Dr. Xia has a proven track record of leading innovative studies aimed at advancing therapeutic interventions. His commitment to rigorous scientific methodologies and ethical standards ensures the integrity and reliability of clinical trials. Dr. Xia's collaborative approach fosters partnerships with academic institutions and industry stakeholders, driving forward the translation of research findings into impactful healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Wei Xia
Principal Investigator
Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported